Get notified when TRAW files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsTraws Pharma reports Q1 2026 financial results in Regulation FD disclosure
Filed May 15, 2026 · Period ending May 15, 2026 · ~1 min read
Key Changes
-
high
Company announced financial results for the quarter ended March 31, 2026 via press release furnished under Regulation FD. Actual figures are in the attached exhibit, not in the 8-K body.
Item 7.01 verify on EDGAR → -
medium
Press release dated May 15, 2026 was attached as Exhibit 99.1. The filing body does not summarize the earnings figures or provide commentary on performance.
Exhibit 99.1 verify on EDGAR →
This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (ADMT 10-K) is open in full — no account needed.
Partner
Trade TRAW commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Source-verified from EDGAR · Narrative written by AI · May 28, 2026 · How we verify